Results 291 to 296 of about 472,035 (296)

Health-economic review of zoledronic acid for the management of skeletal-related events in bone-metastatic prostate cancer

Expert Review of Pharmacoeconomics and Outcomes Research, 2012
Ja Carter, Marc Botteman
exaly  

Bone Metastases and Skeletal-Related Events: Incidence and Prognosis According to Histological Subtype of Lung Cancer

Future Oncology, 2019
Anke Bergmann
exaly  

Incidence of skeletal related events in patients with bone metastasis receiving denosumab every four weeks compared to intervals greater than every four weeks

Journal of Oncology Pharmacy Practice, 2019
Steven Wolf
exaly  

Skeletal-related events in prostate cancer.

Clinical advances in hematology & oncology : H&O, 2013
openaire   +1 more source

Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors

Expert Review of Clinical Pharmacology, 2012
exaly  

Kidney cancer: decreased incidence of skeletal-related events in mRCC.

Nature reviews. Urology, 2015
Takeshi, Yuasa, Shinji, Urakami
openaire   +1 more source